| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Cash | 76,507 | |||
| Accounts receivable | 0 | |||
| Inventory (related party transaction) | 174,788 | |||
| Right of use assets | 0 | |||
| Total assets | 251,295 | |||
| Accounts payable | 0 | |||
| Lease liability | 0 | |||
| Unearned sales revenue | 1,860 | |||
| Unearned service revenue | 62,500 | |||
| Total current liabilities | 64,360 | |||
| Due from the related party | 95,588 | |||
| Long-term liabilities | 189,250 | |||
| Less discount on long-term liabilities | -11,065 | |||
| Total liabilities | 338,133 | |||
| Common stock, 0.0001 par value, 300,000,000 shares authorized, 99,000,000 issued and outstanding at december 31, 2024 99,000,000 issued and outstanding at june 30, 2025 | 9,900 | |||
| Additional paid-in capital | 1,302,504 | |||
| Retained earnings | -1,399,241 | |||
| Total stockholders' equity | -86,838 | |||
| Total liabilities and stockholders' equity | 251,295 | |||
GOLDENWELL BIOTECH, INC. (GWLL)
GOLDENWELL BIOTECH, INC. (GWLL)